A vaccine originally developed more than 100 years ago to fight tuberculosis may soon have a surprising new role. Researchers are exploring whether the Bacillus Calmette-Guérin (BCG) vaccine, widely used to prevent severe forms of tuberculosis, could help improve blood sugar control and reduce insulin dependence in people living with Type 1 diabetes.
